Civica Rx and other nontraditional drug suppliers entering the market say they are seeking to fix a dysfunctional system that puts patients at risk and adds to fast-rising pharmaceutical spending. “It’s really a good idea to shore up our supply of these products. Without these, the alternatives are pretty grim,” said the University of Utah’s Erin Fox.

from Kaiser Health News http://bit.ly/2VFCw8U

Related Posts:

0 comments:

Post a Comment

Popular Posts